🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Epidemiology, Risk Factors, and Outcomes of Infections of Lower Limb MEGAprostheses

Recruitingn/aAges 14 Years - 100 YearsAllIRCCS Azienda Ospedaliero-Universitaria di Bologna
NCT07544212 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Retrospective, multicenter, non-profit observational study. The study will include consecutive patients who underwent lower-limb megaprosthesis implantation at the participating Centers between January 1, 2020, and June 30, 2023.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Age ≥ 14 years * Implantation of a lower-limb megaprosthesis at one of the participating centers between January 1, 2020, and June 30, 2023 * At least 2 years of follow-up after megaprosthesis implantation * Signed informed consent Exclusion Criteria: * None
💊

What it tests

  • Not listed
📍

Where

1 site
Irccs Azienda Ospedaliero-Universitaria Di Bologna
Bologna, Italy
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy